Evidence map›Paper›PMID 40718101›Full record

ArticleFrontiers in neurology2025

Neuropsychiatric disorders among Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder.

Edgar Patricio Correa-Díaz, Ruth Jimbo Sotomayor, Jorge Rubén Pilco Romero, Patricio Alexander Merino Aguilera

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edgar Patricio Correa-DíazDepartment of Neurology, Hospital de Especialidades Carlos Andrade Marín, Quito, Ecuador.
Ruth Jimbo SotomayorPontifical Catholic University of Ecuador, Quito, Ecuador.
Jorge Rubén Pilco RomeroCentral University of Ecuador, Quito, Ecuador.
Patricio Alexander Merino AguileraPontifical Catholic University of Ecuador, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD) are chronic demyelinating diseases of the central nervous system, there is an association between these diseases and neuropsychiatric disorders, which directly impacts the course of the disease and the quality of life of the patients. Objective: To determine the prevalence of psychiatric disorders in patients with MS and NMOSD and its relationship with age and disability. Materials and methods: It is a cross-sectional study, 151 patients were included, 117 patients with MS and 34 patients with NMOSD. Information was obtained by collecting data from records of the patients. In order to establish the diagnoses of anxiety and depression, the Hamilton Depression Rating Scale (HDRS) and the Beck Depression Inventory (BDI) scales were completed. Results: MS and NMOSD were frequent in female sex and mestizo ethnicity. The psychiatric disorders were frequent in both diseases (70.9% in MS and 85% in NMOSD), the most frequent pathologies were anxiety and depression. We found low frequency of attempted suicide. Anxiety and depression were present in patients between 41 and 50 years of age. There is not a correlation between the severity of anxiety and depression with age and disability. Conclusion: It is the first Ecuadorian study in which we established a high prevalence of anxiety and depression in MS and NMOSD patients, the severity of both disease was not related with age and disability.

Indexed as

anxietybipolar disorderdepressionmultiple sclerosisneuropsychiatric disordersoptical neuromyelitispsychosis

Identifiers

PMID40718101
PMCPMC12290892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.